Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 12 of 12 entries
View as:

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01970501 Org: User:
Start: 04/30/14 End: 12/28/17 Due: 12/28/18

Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT00073554 Org: User:
Start: 06/30/03 End: - Due: -

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00499902 Org: User:
Start: 06/30/07 End: 05/31/08 Due: 05/31/09

Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00115999 Org: User:
Start: 04/30/05 End: 02/28/07 Due: 02/28/08

Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32

Phase: N/A Priority: Normal
NCT ID: NCT00116012 Org: User:
Start: 06/30/05 End: - Due: -

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

Phase: N/A Priority: Normal
NCT ID: NCT00322270 Org: User:
Start: 01/31/06 End: - Due: -

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Phase: N/A Priority: Normal
NCT ID: NCT00073515 Org: User:
Start: - End: - Due: -

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04655586 Org: User:
Start: 12/10/20 End: 03/07/22 Due: 03/07/23

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00338585 Org: User:
Start: 04/30/06 End: 03/31/07 Due: 03/31/08

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00443573 Org: User:
Start: 12/31/06 End: - Due: -

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters

Phase: N/A Priority: Normal
NCT ID: NCT00346424 Org: User:
Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00808964 Org: User:
Start: 01/31/13 End: 09/30/13 Due: 09/30/14